Adial Pharmaceuticals Inc (ADIL) — Long-term Investment Intensity
Adial Pharmaceuticals Inc (ADIL) has a Long-term Investment Intensity of 8.1% as of March 2026. Long-term investments of $421.73K represent 8.1% of total assets of $5.23 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check Adial Pharmaceuticals Inc (ADIL) asset resilience to evaluate the company's liquid asset resilience ratio.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Adial Pharmaceuticals Inc Long-term Investment Intensity (2023–2025)
This chart shows how Adial Pharmaceuticals Inc's Long-term Investment Intensity has evolved across 3 annual periods from 2023 to 2025. As of March 2026, the intensity stands at 8.1%, reflecting long-term investments of $421.73K against total assets of $5.23 Million USD. For the complete balance sheet picture, see ADIL total asset value.
Annual Long-term Investment Intensity for Adial Pharmaceuticals Inc (2023–2025)
The table below presents the year-by-year Long-term Investment Intensity for Adial Pharmaceuticals Inc from 2023 to 2025, covering 3 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. Read ADIL liabilities breakdown for a breakdown of total debt and financial obligations.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2025 | 7.2% | $489.70K | $6.80 Million | ▼ -12.3 pp |
| 2024 | 19.5% | $981.83K | $5.04 Million | ▼ -12.9 pp |
| 2023 | 32.4% | $1.53 Million | $4.74 Million | — |